These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33442785)

  • 1. Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity.
    Yang Z; Zhao L; Wang X; He Z; Wang Y
    AAPS PharmSciTech; 2021 Jan; 22(1):46. PubMed ID: 33442785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy.
    Li C; Cui J; Wang C; Li Y; Zhang H; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
    Eur J Pharm Biopharm; 2008 Oct; 70(2):657-65. PubMed ID: 18582570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect.
    Li C; Zhao X; Deng C; Wang C; Wei N; Cui J
    Int J Pharm; 2014 Jan; 460(1-2):165-72. PubMed ID: 24148664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
    Li C; Cui J; Wang C; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
    Int J Pharm; 2008 Oct; 362(1-2):60-6. PubMed ID: 18598745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone.
    Gokhale PC; Pei J; Zhang C; Ahmad I; Rahman A; Kasid U
    Anticancer Res; 2001; 21(5):3313-21. PubMed ID: 11848489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.
    Allijn IE; Czarny BMS; Wang X; Chong SY; Weiler M; da Silva AE; Metselaar JM; Lam CSP; Pastorin G; de Kleijn DPV; Storm G; Wang JW; Schiffelers RM
    J Control Release; 2017 Feb; 247():127-133. PubMed ID: 28065862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
    Cui J; Li C; Wang L; Wang C; Yang H; Li Y; Zhang L; Zhang L; Guo W; Liang M
    Int J Pharm; 2009 Feb; 368(1-2):24-30. PubMed ID: 18973800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
    Lim HJ; Masin D; Madden TD; Bally MB
    J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than Doxil
    Zhang R; Zhang Y; Zhang Y; Wang X; Gao X; Liu Y; Zhang X; He Z; Wang D; Wang Y
    Asian J Pharm Sci; 2020 May; 15(3):385-396. PubMed ID: 32636956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacodynamics, pharmacokinetics and tissue distribution of liposomal mitoxantrone hydrochloride].
    Wang CX; Li CL; Zhao X; Yang HY; Wei N; Li YH; Zhang L; Zhang L
    Yao Xue Xue Bao; 2010 Dec; 45(12):1565-9. PubMed ID: 21351498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.
    Schwendener RA; Fiebig HH; Berger MR; Berger DP
    Cancer Chemother Pharmacol; 1991; 27(6):429-39. PubMed ID: 2013113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
    Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
    Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrone-targeted liposomes for mitoxantrone delivery via estrogen receptor: In vivo targeting efficacy, antitumor activity, acute toxicity and pharmacokinetics.
    Xu G; Tang H; Chen J; Zhu M; Xie Y; Li Y; Hao Q; Sun Y; Cong D; Meng Q; Ren Z; Li Q; Bao H; Lv Z; Li Y; Pei J
    Eur J Pharm Sci; 2021 Jun; 161():105780. PubMed ID: 33667664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
    Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
    Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice.
    Chang CW; Barber L; Ouyang C; Masin D; Bally MB; Madden TD
    Br J Cancer; 1997; 75(2):169-77. PubMed ID: 9010021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of mitoxantrone liposomes and study on its in vivo distribution in rats after transdermal delivery].
    Chen T; Hou SX; Sun YY; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):934-7. PubMed ID: 17236598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
    Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
    Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations.
    Xin Y; Qi Q; Mao Z; Zhan X
    Int J Pharm; 2017 Aug; 528(1-2):47-54. PubMed ID: 28559216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.